Tracked deals
3
3 tracked deals across 2022.
Morristown, New Jersey, United States
Lumanity is a healthcare consultancy focused on cracking the code on the future of healthcare by revolutionizing how value is generated, demonstrated, and communicated—supporting healthcare outcomes and life-sciences commercialization and market access.
Tracked deals
3
3 tracked deals across 2022.
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Addon
3 addon
Last 1 years
Supporting Data
Lumanity, a portfolio company of Arsenal Capital Partners, has acquired Boston-based life sciences consultancy Clarion Healthcare from Svoboda Capital Partners. The undisclosed transaction expands Lumanity’s U.S. commercialization and product lifecycle consulting capabilities and creates greater global scale for life sciences strategy services.
Lumanity has acquired Endpoint Outcomes, a specialist in patient-centered clinical outcomes assessments, to strengthen and broaden its health economics and outcomes research (HEOR) capabilities. The acquisition integrates Endpoint's COA expertise with Lumanity's existing HEOR, medical, commercial, and regulatory capabilities to create a comprehensive global HEOR service offering.
Lumanity, a portfolio company backed by Arsenal Capital Partners, has acquired Innovative Edge (IE), a UK-based provider of pharmaceutical product launch and commercialization services. The add-on strengthens Lumanity's end-to-end commercialization and launch capabilities by integrating IE's Launch EcoSystem and Ignite collaborative launch platform into Lumanity's existing life‑sciences services.
Turn tracked acquisition activity into an outreach-ready buyer list.